{"gao_id": "GAO-20-124", "published": "2019-12-18T12:00:00Z", "released": "2019-12-18T07:00:00Z", "summary": "The Office of National Drug Control Policy (ONDCP) oversees and coordinates federal drug policy. In 2018, new legislation reauthorized ONDCP and imposed a number of new requirements. We found that ONDCP met some of the new requirements. For instance, ONDCP designated officials for two new coordinator positions. However, ONDCP does not have key planning elements needed to ensure it can meet other requirements related to...", "title": "Drug Control: The Office of National Drug Control Policy Should Develop Key Planning Elements to Meet Statutory Requirements", "topics": ["Crisis", "Substance abuse", "Communities", "Authorizing legislation", "Prescription drugs", "Justice and Law Enforcement", "Health care standards", "Performance measurement", "Drug control", "Drug control budgets", "Performance reporting"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-20-124", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-20-124-highlights.pdf"}, {"title": "Full Report (44 pages)", "url": "https://www.gao.gov/assets/gao-20-124.pdf"}, {"title": "Accessible PDF (51 pages)", "url": "https://www.gao.gov/assets/710/706606.pdf"}]}